Healthcare provider profile · identity verified

Daniel V Young, MD

Internal Medicine · WASHINGTON, DC · NPI 1326257825

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	382	113
Levothyroxine Sodium	Levothyroxine Sodium	256	59
Pantoprazole Sodium	Pantoprazole Sodium	244	67
Losartan Potassium	Losartan Potassium	202	58
Escitalopram Oxalate	Escitalopram Oxalate	171	45
Amlodipine Besylate	Amlodipine Besylate	169	51
Ezetimibe	Ezetimibe	153	44
Celecoxib	Celecoxib	118	51
Atorvastatin Calcium	Atorvastatin Calcium	104	26
Azithromycin	Azithromycin	100	75
Gabapentin	Gabapentin	94	36
Eliquis	Apixaban	93	25
Silodosin	Silodosin	93	34
Metoprolol Succinate	Metoprolol Succinate	91	27
Tamsulosin Hcl	Tamsulosin Hcl	84	22
Allopurinol	Allopurinol	82	19
Trazodone Hcl	Trazodone Hcl	80	27
Furosemide	Furosemide	71	23
Doxycycline Hyclate	Doxycycline Hyclate	69	42
Pravastatin Sodium	Pravastatin Sodium	66	20
Olmesartan Medoxomil	Olmesartan Medoxomil	63	19
Finasteride	Finasteride	59	18
Montelukast Sodium	Montelukast Sodium	59	16
Clopidogrel	Clopidogrel Bisulfate	56	14
Famotidine	Famotidine	54	15
Synthroid	Levothyroxine Sodium	54	14
Breo Ellipta	Fluticasone/Vilanterol	53	12
Sertraline Hcl	Sertraline Hcl	53	15
Cefuroxime	Cefuroxime Axetil	52	35
Hydrochlorothiazide	Hydrochlorothiazide	51	13
Zolpidem Tartrate	Zolpidem Tartrate	49	25
Candesartan Cilexetil	Candesartan Cilexetil	48	17
Mirtazapine	Mirtazapine	48	12
Metformin Hcl Er	Metformin Hcl	45	17
Omeprazole	Omeprazole	43	12
Xarelto	Rivaroxaban	41	suppressed
Nebivolol Hcl	Nebivolol Hcl	40	12
Indapamide	Indapamide	39	11
Valsartan	Valsartan	37	12
Buspirone Hcl	Buspirone Hcl	36	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	36	17
Metformin Hcl	Metformin Hcl	36	11
Mounjaro	Tirzepatide	34	suppressed
Mupirocin	Mupirocin	34	26
Vitamin D2	Ergocalciferol (Vitamin D2)	34	suppressed
Donepezil Hcl	Donepezil Hcl	33	suppressed
Dutasteride	Dutasteride	31	suppressed
Jardiance	Empagliflozin	31	suppressed
Pregabalin	Pregabalin	31	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	30	suppressed
Atenolol	Atenolol	30	suppressed
Alprazolam	Alprazolam	29	14
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	28	suppressed
Memantine Hcl	Memantine Hcl	27	suppressed
Potassium Chloride	Potassium Chloride	27	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	26	20
Risperidone	Risperidone	26	suppressed
Valacyclovir	Valacyclovir Hcl	26	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	25	suppressed
Irbesartan	Irbesartan	25	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	25	suppressed
Meloxicam	Meloxicam	25	suppressed
Amoxicillin	Amoxicillin	24	20
Fluticasone Propionate	Fluticasone Propionate	23	suppressed
Bupropion Xl	Bupropion Hcl	22	suppressed
Dexlansoprazole Dr	Dexlansoprazole	22	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	22	suppressed
Simvastatin	Simvastatin	22	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	22	suppressed
Clonidine Hcl	Clonidine Hcl	21	suppressed
Colchicine	Colchicine	21	suppressed
Desloratadine	Desloratadine	21	suppressed
Myrbetriq	Mirabegron	21	suppressed
Farxiga	Dapagliflozin Propanediol	20	suppressed
Namzaric	Memantine Hcl/Donepezil Hcl	20	suppressed
Diazepam	Diazepam	19	suppressed
Estradiol	Estradiol	19	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	19	suppressed
Solifenacin Succinate	Solifenacin Succinate	19	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	19	suppressed
Xigduo Xr	Dapaglifloz Propaned/Metformin	19	suppressed
Azelastine-Fluticasone	Azelastine/Fluticasone	18	suppressed
Duloxetine Hcl	Duloxetine Hcl	18	suppressed
Ipratropium Bromide	Ipratropium Bromide	18	suppressed
Testosterone	Testosterone	18	suppressed
Trimethoprim	Trimethoprim	18	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	18	suppressed
Acyclovir	Acyclovir	17	suppressed
Digoxin	Digoxin	17	suppressed
Lisinopril	Lisinopril	17	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	16	suppressed
Primidone	Primidone	16	suppressed
Tizanidine Hcl	Tizanidine Hcl	16	suppressed
Alendronate Sodium	Alendronate Sodium	15	suppressed
Lamotrigine	Lamotrigine	15	suppressed
Tadalafil	Tadalafil	15	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	15	suppressed
Vascepa	Icosapent Ethyl	15	suppressed
Verapamil Er	Verapamil Hcl	15	suppressed
Mometasone Furoate	Mometasone Furoate	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Aripiprazole	Aripiprazole	13	suppressed
Carvedilol	Carvedilol	13	suppressed
Divalproex Sodium	Divalproex Sodium	13	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	13	suppressed
Folic Acid	Folic Acid	13	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	13	suppressed
Lithium Carbonate	Lithium Carbonate	13	suppressed
Meprobamate	Meprobamate	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Memantine Hcl Er	Memantine Hcl	12	suppressed
Nystatin	Nystatin	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	11
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Aliskiren	Aliskiren Hemifumarate	11	suppressed
Clonazepam	Clonazepam	11	suppressed
Icosapent Ethyl	Icosapent Ethyl	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Potassium Citrate Er	Potassium Citrate	11	suppressed
Rizatriptan	Rizatriptan Benzoate	11	suppressed
Spironolactone	Spironolactone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error